Page last updated: 2024-12-11
pyralene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6454370 |
| SCHEMBL ID | 10696165 |
| MeSH ID | M0060828 |
Synonyms (7)
| Synonym |
|---|
| pyralene |
| pyralene 1500 |
| 62251-11-0 |
| 2h-pyran-6-carbaldehyde |
| 53025-30-2 |
| SCHEMBL10696165 |
| DTXSID20967520 |
Research Excerpts
Overview
Pyralene is a PCB-based transformer oil. It has a unique PCB congener profile when compared to other mixtures.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Pyralene is a PCB-based transformer oil with a unique PCB congener profile when compared to other mixtures. " | ( Effect of a PCB-based transformer oil on testicular steroidogenesis and xenobiotic-metabolizing enzymes. Andric, NL; Andric, SA; Kostic, TS; Kovacevic, RZ; Stanic, BD; Zoric, SN, 2006) | 1.78 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 42.47
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (42.47) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (16.67%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||